Novavax Strikes Licensing Deal with Sanofi for Potential $1.2 Billion
- May 10, 2024
Gaithersburg, MD-based Novavax, Inc. has entered into a licensing agreement valued at up to $1.2 billion with French drugmaker Sanofi, according to a May 10 announcement.
ARTICLE TAGS
You must be logged in to access this content.